TD Asset Management
NVAX icon

TD Asset Management’s Novavax NVAX Stock Holding History

TD Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,115
Closed -$377K – 1499
2022
Q1 		$377K Sell
5,115
-16,268
-76% -$1.45M ﹤0.01% 1369
2021
Q4 		$3.06M Sell
21,383
-15,107
-41% -$2.6M ﹤0.01% 1021
2021
Q3 		$7.57M Buy
36,490
+6,930
+23% +$1.53M 0.01% 718
2021
Q2 		$5.3M Buy
29,560
+4,592
+18% +$841K 0.01% 811
2021
Q1 		$4.53M Buy
24,968
+5,868
+31% +$1.17M 0.01% 853
2020
Q4 		$2.13M Buy
19,100
+8,500
+80% +$903K ﹤0.01% 1019
2020
Q3 		$1.15M Sell
10,600
-1,400
-12% -$171K ﹤0.01% 1064
2020
Q2 		$1M Buy
+12,000
New +$459K ﹤0.01% 1060
2019
Q1 		– Sell
-8,435
Closed -$310K – 1374
2018
Q4 		$310K Buy
+8,435
New +$327K ﹤0.01% 1300
2016
Q3 		– Sell
-28,305
Closed -$4.12M – 1403
2016
Q2 		$4.12M Sell
28,305
-355
-1% -$40.7K 0.01% 727
2016
Q1 		$2.96M Sell
28,660
-180
-0.6% -$19.3K 0.01% 778
2015
Q4 		$4.84M Buy
28,840
+2,000
+7% +$308K 0.01% 666
2015
Q3 		$3.79M Sell
26,840
-530
-2% -$119K 0.01% 705
2015
Q2 		$6.1M Sell
27,370
-255
-0.9% -$44.8K 0.01% 622
2015
Q1 		$4.57M Buy
27,625
+14,150
+105% +$2.3M 0.01% 688
2014
Q4 		$1.6M Buy
13,475
+905
+7% +$94.6K ﹤0.01% 866
2014
Q3 		$1.05M Buy
12,570
+1,060
+9% +$95.8K ﹤0.01% 896
2014
Q2 		$1.06M Buy
11,510
+4,910
+74% +$432K ﹤0.01% 897
2014
Q1 		$598K Sell
6,600
-1,400
-18% -$156K ﹤0.01% 992
2013
Q4 		$819K Sell
8,000
-4,730
-37% -$334K ﹤0.01% 914
2013
Q3 		$805K Buy
+12,730
New +$717K ﹤0.01% 901

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TD Asset Management's NVAX Position: Q2 2022 in Review

TD Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 5,115 shares — an estimated $377K sold.

TD Asset Management first reported a position in NVAX in Q3 2013 and held it in 21 quarters. The position peaked at $7.57M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • TD Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • TD Asset Management sold 5,115 Novavax shares in Q2 2022, an estimated $377K.
  • TD Asset Management first reported a position in Novavax in Q3 2013 and held it in 21 quarters.
  • TD Asset Management's Novavax position peaked at $7.57M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on TD Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.